Does Glucagon-like Peptide (GLP-1) Receptor Agonist Stimulation Reduce Alcohol Intake in Patients With Alcohol Dependence?
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 11 Oct 2019
Price : $35 *
At a glance
- Drugs Exenatide (Primary)
- Indications Alcoholism
- Focus Therapeutic Use
- Acronyms EXALT
- 08 Oct 2019 Planned primary completion date changed from 1 Apr 2020 to 15 Apr 2020.
- 08 Oct 2019 Status changed from recruiting to active, no longer recruiting.
- 30 Jul 2019 Planned End Date changed from 1 Nov 2019 to 1 Dec 2020.